
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Winston-Salem, N.C. -- Clinical practice experience indicates that tacrolimus ointment (Protopic) is safe and effective for treatment of moderate to severe atopic dermatitis in children less than two years of age, Alan B. Fleischer Jr., M.D., said.